Promising MS Stem Cell Trial Advances to Next Phase
May 31, 2024 Prof. Dimitrios Karussis, head of the Hadassah Medical Organization’s Multiple Sclerosis Center, is embarking on the next…
TISCH MS Research Center of NY – Now Published: Our Phase II Clinical Trial Results in Stem Cell Therapy
Now Published: Our Phase II Clinical Trial Results Hello, We are excited to share that results of our Phase…
Stuart Schlossman
HSCT (haematopoietic stem cell transplant) – short summary
Summary HSCT (haematopoietic stem cell transplant) is not a drug, it is a procedure that involves harvesting of stem cells…
Stuart Schlossman
Stem cell therapy highly effective in active RRMS: Real-world study
Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Stem cell therapy highly effective in active RRMS:…
Stuart Schlossman
TISCH MS Research Center News: Phase II results of our FDA-approved stem cell treatment study have been released
We are very excited to share that the highly-anticipated Phase II results of our FDA-approved stem cell treatment study…
Stuart Schlossman
MS Relapse Rates Drop to Zero Following Stem Cell Transplants — But ‘Risks Are Real,’ Study Says
Medically reviewed by Evelyn O. Berman, M.D. KEY TAKEAWAYS People with multiple sclerosis (MS) who undergo hematopoietic stem cell transplantation…
Stuart Schlossman
New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease
Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Centerof New York found that stem cell treatments substantially improved…
Stuart Schlossman
Hadassah Medical Organization Announces Breakthrough in Stem Cell Treatment for MS and ALS
WEDNESDAY, MARCH 2, 2022 MEDIA CONTACTAlix Friedmanafriedman@hadassah.org New York, NY – Hadassah Medical Organization announces the first objective evidence that stem cells injected…
Stuart Schlossman
Israeli study: Stem cells may help multiple sclerosis brain ‘repair itself’
Eight of 15 patients who receive NG-01 therapy as spinal injection see better disability scores; inventors say therapy may ‘dramatically…
Stuart Schlossman
Stem Cell Transplant Induces Multiple Sclerosis Remission
At a Glance Immunosuppressive therapy followed by stem cell transplantation induced remission of a common form of multiple sclerosis…
Stuart Schlossman
